Senior Vice President
Eurofins U.S. Clinical Diagnostics
David Morgan serves as President of Viracor Eurofins. Mr. Morgan is a healthcare executive with 20 years of experience running various-sized private companies and large divisions of public companies. He has also served on several for-profit and not-for-profit Boards of Directors. Prior to joining Viracor, Mr. Morgan was President and CEO of Vantage Point Holdings, Inc., a private equity-backed group of diagnostic companies that were sold to Sonic Heathcare in January of 2017. Before his time at Vantage Point Holdings, Mr. Morgan held senior executive positions at Cogent Healthcare, Beacon Bay Holdings, and Laboratory Corporation of American. Mr. Morgan began his career with US LABS, Inc., where he held several management positions culminating as Vice President of Operations when the company was sold to LabCorp in 2006. Following the acquisition by LabCorp, Mr. Morgan remained with the company where he held several general management positions as both Vice President and Senior Vice President. Mr. Morgan was responsible for integrating LabCorp’s many Oncology and Anatomic Pathology companies into its Oncology Division, which later become known as Integrated Oncology. Prior to his career in healthcare, Mr. Morgan was a 10 year veteran of the United States Marine Corps. He holds a Bachelor’s degree from University of Pittsburgh and a Master’s degree from Central Michigan University.